FORL
Four Leaf Acquisition Corp
$11.00
0.00%
No data for this timeframe.
Vol
Inst. Holders3 funds
Inst. Value$2.8M
Inst. Activity1 buys / 0 sells
SEC Reports1
Recent Activity
Jun 4, 2026
SEC
Four Leaf Acquisition Corp (FORL) announced the immediate resignation of Interim CEO and Chairman Bala Padmakumar, effec
8-K — Impact 2/10
Inst.
MORGAN STANLEY — ADD
12 shares ($138.00)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — TRIM
185,500 shares ($2.2M)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | $2.2M | TRIM |
| Clear Street Group Inc. | $592.5K | — |
| MORGAN STANLEY | $138.00 | ADD |
3 institutional holders with $2.8M total value (236,207 shares) as of 2025-Q3. Top holders: WOLVERINE, Clear, MORGAN. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WOLVERINE ASSET MANAGEMENT LLC | 184,630 | $2.2M | 78.9% | TRIM -27.9% |
| 2 | Clear Street Group Inc. | 51,565 | $592.5K | 21.1% | — |
| 3 | MORGAN STANLEY | 12 | $138.00 | 0.0% | ADD +71.4% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 7 | 12 | +71.4% | $138.00 | 2025-Q3 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 257,153 | 185,500 | -27.9% | $2.2M | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.